In a double-blind randomized non-crossover trial 47 patients received either morphine or buprenorphine by regular l.m. injection for 24 h after abdominal surgery. The two drugs were equally effective as analgesics at the doses used Five in the buprenorphine group and none in the morphine group were excluded because of respiratory depression Four of these had received opiates during operation The remainder of the buprenorphine group developed progressively slower respiration rates after 12 h The results indicate that buprenorphine has a synergistic respiratory depressant effect with fentanyl and phenopendine and may have a cumulative effect when given regularly on a 6-hourly regimen
Buprenorphine is a relatively new synthetic opiate analgesic with a chemical structure similar to morphine (Lewis, 1974; Downing, Leary and White, 1977) . Published studies indicate that the drug has a high affinity for the opiate receptor with a long duration of action (Downing, Leary and White, 1977; Kay, 1978) . Clinical studies have confirmed that its analgesic potency (w/w) is about 30 times that of morphine. Previous studies comparing buprenorphine with morphine i.m. have used ratios 0.6:15mg (1:25) and 0.3:12.5 mg (1:42). The smallest recommended i.m. dose (0.3 mg) has been found to be at least as effective as morphine lOmg, but has a longer duration of action of 6-18 h (Downing, Leary and White, 1977; Kay, 1978 Kay, , 1980 . Larger doses (1 mg) have been shown to produce miosis for more than 72 h (Jasinski, Pevnick and Griffith, 1978) . The drug is also a narcotic antagonist and Jasinski showed that very large doses (8mg) are capable of blocking the effects of large doses of morphine (up to 120mg) for more than 30 h.
Only limited pharmacokinetic data are available. In an early unpublished study in man, the elimination half-life of labelled buprenorphine appeared to be more than 12 h and possibly more than 24 h. A recent study using radioimmunoassay found a mean terminal half-life of 3+1.7 (SD)h, but this may be an underestimate since the sampling period was only 3 h (Bullingham et al., 1980) . All published studies on the parenteral use of the drug have involved single doses or multiple doses on demand. The present study was designed to compare the efficacy and side-effects of buprenorphine and morphine following regular i.m. injection in patients recovering from surgery, using an average dose and dose ratio of the two drugs.
METHODS
Forty-seven patients aged 18-70 yr and weighing 40-90 kg who were undergoing abdominal surgery gave informed consent to the trial, which had been approved by the hospital ethics committee. Most patients received diazepam 10 mg orally as premedication, i.v. thiopentone for induction of anaesthesia and nitrous oxide and halothane or trichloroethylene or opiates for maintenance. Additional anaesthesia and analgesia were given according to the anaesthetist's preferences and all drugs administered were recorded.
After operation patients received either buprenorphine 0.3 or 0.45 mg or morphine 10 or 15 mg i.m. (dose ratio 1:33) according to weight (less than or greater than 63 kg). The drugs were administered according to a randomized doubleblind non-crossover design. The first dose was given when the patient wakened in the recovery room and subsequent doses were given regularly every 6h for 24 h. The patients were attended by trained nurse observers for 24 h after operation.
Baseline heart rate, arterial pressure and breathing rate were noted before operation and repeated immediately before each postoperative injection, to give an assessment of the changes present 6 h after each injection. Pain assessments and additional recordings were made before and 1 h after the 6-h and 24-h injections. The amount of pain was assessed independently by the nurse and the patient using a visual analogue scale consisting of a 100-mm line joining the two extremes marked "no pain" (Omm) and "unbearable pain" (100 mm). All symptoms and side-effects were noted throughout the period of observation. Nausea and vomiting were treated with metoclopramide 10 mg i.m. as necessary. Provision was made for patients to be withdrawn from the study by the doctor in charge of the case or at their own request because of inadequate analgesia, unacceptable side-effects or complications.
RESULTS

Patient comparability
The age, sex and weight distribution and dose per kg body weight were similar in the two groups (table I). The mean buprenorphine: morphine dose ratio was 1 :36 in the lighter patients and 1:33 in the heavier patients. The premedication, anaesthetic induction and maintenance, the neuromuscular blocking drug and the procedures for its antagonism were similar in both groups. Eleven of the morphine group and eight of the buprenorphine group received opiate analgesia during the operation. One patient in the morphine group who received pethidine was given naloxone 0.3 mg at the end of the operation.
Side-effects and withdrawals
The frequency of nausea and vomiting was similar in the morphine (seven patients) and buprenorphine (eight patients) groups. One patient in each group developed a chest infection during the trial period.
Six patients in the buprenorphine group and one patient in the morphine group were withdrawn (Fisher's exact test: P = 0.042). One patient in each group was withdrawn because of inadequate analgesia and the remaining five patients in the buprenorphine group were withdrawn because of respiratory depression (table  II) . One in the morphine group developed serious respiratory depression 2.5 h after the end of the trial and received naloxone. Four of the five in the buprenorphine group had received opiate analgesia during the operation. Three of these were withdrawn within 6 h and the remaining patient, who had been noted to have some respiratory depression at 6 h, was withdrawn at 11 h. The patient who had received no previous opiate analgesia was withdrawn at 18 h.
Pain assessment
The results of the nurse observer and patient pain scores are in table III. There was good agreement between the two assessments. Both drugs were associated with a highly significant degree of pain relief with about a 50-60% reduction in pain score recorded 1 h after injection.
Cardiovascular changes
There were no significant differences in respect of systolic and diastolic arterial pressures or the heart rate between the two groups.
Respiratory rate
The respiratory rates before and after operation were similar in the two groups (table IV) . Those patients who received opiate analgesia during operation had similar respiratory rates after operation compared with those who did not. The mean respiratory rates in the buprenorphine group were less than those in the morphine group at both 1 h (Anovar: P = < 0.05) and 6 h (Anovar: P = < 0.005) after injection. The differences are confirmed if the changes in respiratory rates from the preoperative values are compared in the two groups of patients ( fig. 1 ). The graph shows that both groups had an increased mean respiratory rate immediately after operation; whereas the morphine group returned to the preoperative value by 24 h, the mean respiratory rate in the buprenorphine group continued to decrease to less than the preoperative value after 12 h.
DISCUSSION
The degree of analgesia recorded at 1 and 6 h after injection was similar in the two groups, confirming that the doses used were equipotent. The larger number of withdrawals in the buprenorphine group may have produced an underestimate of its analgesic potency, and the trial design did not allow an accurate comparison of the duration of analgesic effect.
Respiratory frequency increased after operation in both groups of patients, presumably because rapid shallow breathing caused abdominal pain to be less. The significant reduction in respiratory rates 1 h after injection could be explained by both an analgesic effect and a respiratory depressant effect. These two effects can be distinguished by comparison with the basal respiratory frequencies ( fig. 1 ). I.m. buprenorphine given 6-hourly tended to produce very slow respiratory rates and these mean values would probably have been smaller if the five patients with excessive respiratory depression had remained in the trial. Morphine 6-hourly did not depress the mean respiratory rate significantly below the preoperative value. This result indicates that the effect of buprenorphine on respiration is a direct effect not attributable to analgesia alone, and supports previous observations that it has a greater potential than morphine to produce respiratory depression (Orwin et al., 1976a; Baster, Gibbs and Richardson, 1977) .
Buprenorphine is a potent opiate antagonist as judged by its ability to produce a withdrawal reaction in dependent primates and its ability to antagonize the effects of morphine in man, and it has been recommended as an effective antagonist following the use of fentanyl during surgery in man (De Castro, 1976) . It would be expected to be safe when used after opiates administered during operation in man. However, four of the eight buprenorphine group, but none of the morphine group, who received fentanyl or phenoperidine during operation in this study had evidence of respiratory depression within 6 h (Fisher's exact test: P = 0.051). The result suggests that a synergistic respiratory depressant effect can occur with these two opiates but not, apparently, with pethidine.
Fentanyl and phenoperidine have relatively short elimination half-lives-less than 3h at the doses used (Schleimer et al., 1978; Milne et al., 1980) , and will be almost completely eliminated 6-8 h after a dose.
The progressive reduction in mean respiratory rates was seen in the buprenorphine patients even after the peroperative opioid group was excluded. This reduction can only be explained as evidence of plasma accumulation, which would indicate a true plasma half-life of more than 4 h (Wagner, 1967) or receptor accumulation which greatly outlasted the plasma concentration. Serial plasma estimations during regular dosing would answer the question if plasma accumulation occurs. In either case, accumulation would be reduced by extending the dosing interval to 8-hourly and the drug can still provide effective analgesia when given in this way (Kay, 1980) . These observations need further confirmation. Meanwhile caution should be exercised when buprenorphine is given in addition to other opiate analgesia or when the drug is given by regular i.m. injection. This is particularly important when it is remembered that the respiratory depression by the drug is only partially antagonized by naloxone (Orwin et al., 1976b) 
SUMARIO
En un ensayo doble-ciego no-cruzado al azar, se administro a 47 pacientes ya sea morfina ya sea buprenorfina por inyeccion lm regular durante 24 h despucs de la cirujia abdominal. Ambas substancias fueron igualmente eficaces como analgesicos en las dosis usadas. Cinco pacientes en el grupo de buprenorfina y ninguno en el grupo de morfina feuron excluidos a raiz de una depresi6n respiratoria. Cuatro de ellos habian recibido opiatos durante la operacion. El resto del grupo de buprenorfina desarrollo paulattnamente ritmos de respiracion mas lentos despues dc 12 h. Los resultados indican que la buprenorfina posee un efecto depresivo de la respiracion sinergisuca con el fcntanilo y la fenopendina y puede tener un efecto cumulauvo cuando se adnumstra regularmente bajo un regimen horano de 6 h.
